BACKGROUND The WHO 'Global Strategy for Dengue Prevention and Control, 2012-2020' addresses the growing need for the treatment of dengue, and targets a 25% reduction in morbidity and 50% in mortality (using 2010 estimates as baseline). Achieving these goals requires future dengue prevention strategies that will employ both potential vaccines and sustainable vector-control measures. Maternally t...

Oral mass vaccination (OMV) is considered as an efficient strategy for controlling classical swine fever (CSF) in wild boar. After the completion of vaccination, the presence of antibodies in 6-12 month-old hunted wild boars was expected to reflect a recent CSF circulation. Nevertheless, antibodies could also correspond to the long-lasting of maternal antibodies. This paper relates an experienc...

Abstract Alloimmunization due to anti-M antibodies are rare since they present as naturally occurring immunoglobulin M antibodies, which do not cross the placenta. Very rarely, these may convert G and cause hemolytic disease of fetus newborn. We case a fifth gravida, with previous two miscarriages an unexplained stillbirth, booked us for 8 weeks. At booking, she was found have titers 1:2, stabl...

Abstract Neonatal thyrotoxicosis is mostly caused by the transplacental passage of maternal thyroid stimulating hormone (TSH) receptor antibodies (TRAb) to fetus. Although rare and transient, this condition may be associated with significant morbidity mortality if not diagnosed treated in an appropriate timely manner. Anti-thyroid drugs are main therapy. Here, we report a preterm newborn that p...

BACKGROUND Pertussis booster vaccine (Tdap) recommendations assume that pertussis-specific antibodies in women immunized preconception, during, or after previous pregnancies persist at sufficient levels to protect newborn infants. METHODS Pertussis-specific immunoglobulin G (IgG) was measured by IgG-specific enzyme-linked immunosorbent assay (ELISA) in maternal-umbilical cord serum pairs wher...

Red cell alloimmunisation in pregnancy may result haemolytic disease of the foetus and newborn (HDN). During pregnancy, there are possibilities foetal antigen being exposed to mother’s circulation, thereby leading production antibodies. The immunoglobulin G (IgG) antibodies from mother pass through maternal surface placenta, which is then sensitised obstructs formation red blood cells (RBCs). T...

Summary Neonates are born with an immature immune system and rely on the transfer of immunity from their mothers. Maternal antibodies transferred via placenta breast milk. Although role placentally immunoglobulin G (IgG) is established, less known about selection milk mechanisms by which they provide protection against neonatal disease. Evidence suggests that play multifaceted roles, p...

Pregnancy markedly alters the normal physiology of the women and immune response mechanisms. During normal pregnancy the immune system is reinforced to maintain the well-being of the mother and fetus by modifying the manner that a mother responds to the environment, in such a way that recognition, communication, trafficking and repair mechanisms are all uniformly regulated. In spite of the fact...

Clinical manifestation of the disease caused by chicken anaemia virus (CAV) occurs when chicks are vertically contaminated or before second week life. CAV control is based on vaccination broiler breeders in order to promote progeny protection through maternal antibodies. This work aims evaluate, under field conditions, antibody title commercial at 28, 48, and 68 weeks age, rate transference pro...